Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics

Area of Science:

• Molecular Biology
• Biochemistry
• Developmental Biology

Background:

• The Wnt signaling pathway regulates crucial cellular processes like proliferation, apoptosis, and migration.
• It involves secreted glycoproteins interacting with Frizzled receptors, initiating intracellular cascades.
• This pathway is vital for normal developmental biology.

Purpose of the Study:

• To review recent advancements in small-molecule inhibitors targeting the Wnt signaling pathway.
• To highlight the therapeutic potential of these inhibitors for anticancer treatments.

Main Methods:

• Literature review focusing on small-molecule inhibitors of Wnt signaling.
• Analysis of progress from lead compound discovery to potent therapeutic agents.

Main Results:

• Identification of various small-molecule inhibitors targeting different Wnt pathway components.
• Demonstration of significant therapeutic potential in preclinical and clinical studies.

Conclusions:

• Aberrant Wnt signaling is implicated in numerous human pathologies, including cancer initiation, growth, and metastasis.
• Inhibiting the Wnt signaling pathway presents a promising strategy for developing new anticancer drugs.
• Ongoing research focuses on optimizing small-molecule inhibitors for enhanced efficacy and safety.